On Thursday, Pernix Therapeutics Holdings Inc (NASDAQ:PTX)’s shares inclined 0.75% to $5.34.
Bellamy Young, actress and singer, best known for her role as First Lady ‘Mellie’ Grant on ABC’s drama “Scandal”, has partnered with Pernix Therapeutics (PTX), the makers of TREXIMET®, to share her experience with migraines in conjunction with National Migraine Awareness Month. As one of the more than 36 million Americans1 who suffer from migraines, Bellamy hopes to drive national awareness of the impact migraines can have, particularly in the summer when warmer weather and shifts in daily routines may trigger symptoms.
As Bellamy is well aware, the unpredictable, intense pain of migraines often impacts sufferers’ personal and professional lives in a meaningful way. In fact, a new survey conducted by Everyday Health, Inc., on behalf of Pernix Therapeutics revealed that 8 in 10 female migraine sufferers2said having migraines makes them feel less in control of their lives, while half agreed their personal relationships suffer because of their migraines.
The survey also found:
- Female migraine sufferers get frustrated (87%) when they feel like they have done everything right, yet still have migraines.
- While only 36% of physicians ask about how migraines have affected their careers, nearly all (96%) female migraine suffers find it difficult to work when they have migraines and almost half (48%) have missed at least one day of work in the past month due to migraines.
- Migraine suffering moms feel especially guilty (91%) when they miss out on quality time with their children because of their migraines.
Female migraine sufferers spend an average of 4 hours per week planning for a potential migraine and few women (29%) are very satisfied with their prescription medication. Fortunately, there are solutions that may assist manage the unpredictable nature of migraines to allow sufferers to take back control when a migraine starts.
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The companys product comprise CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product.
Fortinet Inc (NASDAQ:FTNT)’s shares gained 0.64% to $41.97.
Fortinet Inc (FTNT) a global leader in high-performance cyber security solutions, declared that Swisscom (SCMN.VX), the major telecom operator in Switzerland, has selected FortiGate® high performance data center firewall, FortiManager™ security administration appliance and FortiAnalyzer™ network security logging, analysis and reporting solutions to protect vital data center infrastructure. Fortinet’s ability to virtualize high performance firewall capabilities was central to Swisscom’s investment, future proofing the scale and flexibility of security for its service delivery data center.
Swisscom is the largest telecom operator in Switzerland, with over 21,000 employees and annual turnover of over 11bn EUR. The company offers mobile communications, fixed networks, Internet and digital TV services to millions of corporate and residential customers.
The security of its service delivery infrastructure is an important component of the Swisscom 2020 corporate strategy. “A key part of our long-term strategy is to build the best possible data center infrastructure for over 100 different customer-facing services, and to achieve this we’ve chosen Fortinet as our solution for high-performance firewalling,” said Gianpiero Tavano, network and security development engineer at Swisscom.
Fortinet, Inc. provides cyber security solutions for enterprises, service providers, and government organizations worldwide. The company offers FortiGate physical and virtual appliances products that provide various integrated security and networking functions to protect data, applications, and users from network- and content-level security threats; FortiManager product family to manage the system configuration and security functions of multiple FortiGate devices from a centralized console; and the FortiAnalyzer product family, which enables the collection, analysis, and archiving of content and log data generated by its products. It also offers FortiAP secure wireless access points; FortiWeb that provides security for Web-based applications; FortiMail for multi-featured messaging security; FortiDB for centrally managed database-specific security; FortiClient, an endpoint security product for desktops, laptops, and mobile devices; FortiScan for endpoint vulnerability assessment and remediation; and FortiSwitch Ethernet switches.
At the end of Thursday’s trade, AMC Networks Inc (NASDAQ:AMCX)‘s shares surged 1.84% to $82.01.
Topeka Capital analyst David W. Miller downgraded the rating on AMC Networks Inc ( AMCX) from Buy to Hold, with an $85 price target. The stock has risen 28.6 percent in 2015 alone, reflecting a drastic shift in sentiment towards it.
In 2014, the stock was pressured by certain fund redemptions in April and May, together with EBIT and EPS miss in 2Q14, driven by higher program amortization. In addition, the spin-off series of “Breaking Bad,” “Better Call Saul,” was shifted from 3Q14 to 1Q15. The company was already facing tough comps, given that the final season of “Breaking Bad” aired in 3Q13.
The analyst anticipates the company to deliver double-digit revenue, EBITDA and EPS growth in H2, the most rapid growth rate in 2H2015 among AMC Networks’ media peers. However, if “Humans” and “Badlands” fail to succeed, there could be downside risk to the stock. On the other hand, if they do better than “Walking Dead,” there could be upside to the estimates.
AMC Networks Inc. owns and operates various cable television’s brands delivering content to audiences, and a platform to distributors and advertisers in the United States and internationally. The company operates in two segments, National Networks, and International and Other.
Automatic Data Processing (NASDAQ:ADP), ended its Thursday’s trading session with -0.33% loss, and closed at $83.35.
Automatic Data Processing (ADP) will host a client insight roundtable at their state-of-the-art ADP Innovation Lab in New York City. The eleven participants attending this event were awarded the trip as winners of a client video testimonial contest called Insights2Innovation and will have the opportunity to share their perspectives and insights with ADP’s thought leaders and innovators in human resource administration.
The Insights2Innovation video contest was created to allow clients of ADP’s HR BPO solutions to articulate the challenges they face, and share perspectives on how they are partnering with ADP to overcome them. The roundtables and focus groups taking place during the event will seek to explore attendees’ thoughts on a multitude of HR issues counting employee engagement and retention; differences in the needs of multiple generations in workforce; compliance with the Affordable Care Act and other regulations, and other key business issues.
Automatic Data Processing, Inc., together with its auxiliaries, provides technology-based outsourcing solutions to employers worldwide. The company operates through Employer Services and Professional Employer Organization (PEO) Services segments. The Employer Services segment offers a range of business outsourcing and human capital administration (HCM) solutions, counting payroll services, benefits administration services, talent administration solutions, human resources administration solutions, time and attendance administration solutions, insurance services, retirement services, and tax compliance and payment solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
